(Q36569120)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19346378%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

title

Association of treatment of American cutaneous leishmaniasis prior to ulcer development with high rate of failure in northeastern Brazil (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19346378%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

main subject

Brazil

0 references

cutaneous leishmaniasis

1 reference

mucocutaneous leishmaniasis

inferred from title

1 reference

Alon Unger

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19346378%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Seth O'Neal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19346378%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Paulo R L Machado

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19346378%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Luiz H Guimarães

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19346378%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Daniel J Morgan

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19346378%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Albert Schriefer

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19346378%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Olívia Bacellar

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19346378%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Marshall J Glesby

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19346378%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Edgar M Carvalho

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19346378%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

language of work or name

English

0 references

publication date

1 April 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19346378%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Tropical Medicine and Hygiene

25 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19346378%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

volume

80

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19346378%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19346378%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

page(s)

574-579

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19346378%20AND%20SRC:MED&resulttype=core&format=json

Clinical and parasite species risk factors for pentavalent antimonial treatment failure in cutaneous leishmaniasis in Peru.

25 January 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3557504

Influence of Leishmania (Viannia) species on the response to antimonial treatment in patients with American tegumentary leishmaniasis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3557504

Oral pentoxifylline combined with pentavalent antimony: a randomized trial for mucosal leishmaniasis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3557504

Decreased in situ expression of interleukin-10 receptor is correlated with the exacerbated inflammatory and cytotoxic responses observed in mucosal leishmaniasis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3557504

Advances in leishmaniasis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3557504

Old world leishmaniasis: an emerging infection among deployed US military and civilian workers

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3557504

Leishmaniasis: current situation and new perspectives

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3557504

Up-regulation of Th1-type responses in mucosal leishmaniasis patients

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3557504

T-cell-mediated immune responses in patients with cutaneous or mucosal leishmaniasis: long-term evaluation after therapy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3557504

Comparison of cutaneous leishmaniasis due to Leishmania (Viannia) braziliensis and L. (V.) guyanensis in Brazil: therapeutic response to meglumine antimoniate.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3557504

Natural history, clinical evolution, and the host-parasite interaction in New World cutaneous Leishmaniasis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3557504

Treatment failure in children in a randomized clinical trial with 10 and 20 days of meglumine antimonate for cutaneous leishmaniasis due to Leishmania viannia species

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3557504

Epidemiology of American cutaneous leishmaniasis due to Leishmania braziliensis braziliensis.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3557504

Natural history of cutaneous and mucocutaneous leishmaniasis

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3557504

Activated inflammatory T cells correlate with lesion size in human cutaneous leishmaniasis

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3557504

American cutaneous leishmaniasis unresponsive to antimonial drugs: successful treatment using combination of N-methilglucamine antimoniate plus pentoxifylline

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3557504

Failure of early treatment of cutaneous leishmaniasis in preventing the development of an ulcer

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3557504

Successful treatment of refractory mucosal leishmaniasis with pentoxifylline plus antimony

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3557504

Down-regulation of Th1 type of response in early human American cutaneous leishmaniasis

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3557504

Cytokine profile and pathology in human leishmaniasis

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3557504

Randomized, Double‐Blind Study of Stibogluconate Plus Human Granulocyte Macrophage Colony‐Stimulating Factor versus Stibogluconate Alone in the Treatment of Cutaneous Leishmaniasis

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3557504

Lymphadenopathy associated with Leishmania braziliensis cutaneous infection

21 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3557504

Immunological and genetic evidence for a crucial role of IL-10 in cutaneous lesions in humans infected with Leishmania braziliensis

21 October 2018

1 reference

12 December 2020

Epidemiologic and immunologic findings for the subclinical form of Leishmania braziliensis infection

1 reference

12 December 2020

Evidence of in situ cytotoxicity in American cutaneous leishmaniasis

1 reference

12 December 2020

Clinical and diagnostic aspects of American tegumentary leishmaniosis in soldiers simultaneously exposed to the infection in the Amazon Region

1 reference

12 December 2020

Possible risk factors in development of mucosal lesions in leishmaniasis

1 reference

12 December 2020

Clinical characteristics of human Leishmania braziliensis braziliensis infections

1 reference

12 December 2020

Cell mediated immunity in American cutaneous and mucosal leishmaniasis

1 reference

12 December 2020

Selection of a skin test antigen for American visceral leishmaniasis

1 reference

12 December 2020

In situ identification of Leishmania amazonensis associated with diffuse cutaneous leishmaniasis in Bahia, Brazil

1 reference

12 December 2020

The natural history of cutaneous leishmaniasis in Guatemala

1 reference

12 December 2020

Leishmaniasis recidiva cutis in American cutaneous leishmaniasis

1 reference

12 December 2020

Clinical and immunopathological aspects of disseminated cutaneous leishmaniasis

1 reference

12 December 2020

Serum levels of tumor necrosis factor in patients with American cutaneous leishmaniasis

1 reference

12 December 2020

Lymphadenopathy as the first sign of human cutaneous infection by Leishmania braziliensis

1 reference

12 December 2020

Polar and subpolar diffuse cutaneous leishmaniasis in Brazil: clinical and immunopathologic aspects

1 reference

12 December 2020

[Comparative study of meglumine antimoniate, pentamidine isethionate and aminosidine sulfate in the treatment of primary skin lesions caused by Leishmania (Viannia) braziliensis]

1 reference

12 December 2020

Variation of cytokine patterns related to therapeutic response in diffuse cutaneous leishmaniasis

1 reference

12 December 2020

Risk factors for mucosal manifestation of American cutaneous leishmaniasis

1 reference

12 December 2020

[Factors associated with treatment failure of cutaneous leishmaniasis with meglumine antimoniate]

1 reference

12 December 2020

Effect of combination therapy with systemic glucantime and pentoxifylline in the treatment of cutaneous leishmaniasis

1 reference

12 December 2020

Influence of helminth infections on the clinical course of and immune response to Leishmania braziliensis cutaneous leishmaniasis

1 reference

12 December 2020

10.4269/AJTMH.2009.80.574

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19346378%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19346378%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

PubMed publication ID

19346378

1 reference